Oura is acquiring AI primary care firm Counsel Health for $625 million, a move designed to integrate board-certified physicians and 24/7 medical AI directly into the Oura app.
This transition aims to evolve the smart ring from a passive sleep tracker into a proactive “doctor in your pocket” by year-end.
Oura entered a definitive agreement to purchase Counsel Health for $625 million, according to ZDNET. This acquisition marks the third such move by Oura this year, following the earlier purchases of Galen AI and gesture-recognition developer Doublepoint AI. The deal is expected to finalize by the end of the year.
Counsel Health was already a functional partner within the Oura ecosystem. By bringing the company in-house, Oura plans to bridge the gap between biometric data collection and clinical intervention. The integration focuses on addressing episodic health conditions, chronic care, and specialized needs including cardiometabolic, reproductive, and aging-related health.
The Oura Ring currently utilizes its sensor suite to establish a user’s physiological baseline. ZDNET reports that the device can often detect deviations—such as elevated body temperature or increased resting heart rate—before a user exhibits overt symptoms. However, the current utility often stops at data visualization.
“Oura tells members what’s happening in their bodies, and Counsel helps them act on it,” said David Shuman, executive chairman of Oura, in a press release. The platform intends to use Counsel’s medical AI and physician network to provide context to these alerts. This could potentially allow users to receive guidance or prescriptions for minor illnesses directly through the application.
The integration seeks to address the logistical friction of the modern healthcare system. For many users, particularly in high-density urban environments, obtaining a same-day appointment with a primary care provider is difficult. This often forces patients to rely on urgent care clinics for minor, episodic health issues.
The Oura app uses Counsel’s infrastructure to provide an alternative for symptom management. Whether this access to medical professionals and AI-driven triage will be included in the standard Oura subscription or gated behind a premium tier remains unknown. The company has yet to clarify the pricing structure for these clinical services.
Oura’s recent acquisition spree reveals a clear architectural strategy. By integrating Galen AI, which connects biometric data to medical records, and now Counsel Health, Oura is building a closed-loop health platform. The acquisition of Doublepoint AI suggests the company is also looking at new input modalities, such as gesture controls, to refine how users interact with this data.
The acquisition deal is slated to close by the end of the year.
